Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsAlfred H. Schinkel, Piet Borst, Ulrich Mayer et al.|Proceedings of the National Academy of Sciences|1997Cited by 941
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.W. Martin Kast, C J Melief, Lisa Roux et al.|Proceedings of the National Academy of Sciences|1991Cited by 328
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytesW. Martin Kast, Cornelis J.M. Melief, Rienk Offringa et al.|Cell|1989Cited by 300
Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.W. Martin Kast, C J Melief, Claire J. P. Boog et al.|The Journal of Immunology|1988Cited by 69
Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.Nico J. Stam, H. L. Ploegh, W. Martin Kast et al.|The Journal of Immunology|1989Cited by 40